Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. | Director | Common Stock | 73.7K | $92.9K | $1.26 | Jun 6, 2024 | Direct |
Akebia Therapeutics, Inc. | Director | Stock Option (Right to buy) | 45K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
AKBA | Akebia Therapeutics, Inc. | Nov 1, 2021 | 1 | $0 | 4 | Nov 3, 2021 | Director |
AKBA | Akebia Therapeutics, Inc. | Nov 1, 2021 | 0 | $0 | 3 | Nov 3, 2021 | Director |